Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06243835 · ClinicalTrials.gov registry record · Phase 1
A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults
A Phase 1 study, sponsored by Lohocla Research Corporation.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT06243835 is a Phase 1 study that was terminated before completion, run by Lohocla Research Corporation. The registered enrollment target is 16 participants.
The verdict
NCT06243835, a Phase 1 study, was terminated before completion, sponsored by Lohocla Research Corporation.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this study is to test Kindolor in healthy adults. The main questions it aims to answer are: * What is the safe dose of Kindolor in healthy volunteers? * How is Kindolor metabolized by the human body? Participants will undergo medical tests before and after receiving Kindolor or a placebo to see if there is any difference between the groups.
Interventions
- DRUG Placebo
- DRUG Kindolor Tosylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-04-21 |
| Est. Completion | 2025-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06243835
The ClinicalTrials.gov registry entry for NCT06243835 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lohocla Research Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06243835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06243835 about?
NCT06243835 is a clinical study titled "A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults". The goal of this study is to test Kindolor in healthy adults. The main questions it aims to answer are: * What is the safe dose of Kindolor in healthy volunteers? * How is Kindolor metabolized by the human body? Participants will undergo medical tests before and after receiving Kindolor or a place...
What is the current status of trial NCT06243835?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2024-04-21. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT06243835?
The interventions under investigation include: Placebo (DRUG), Kindolor Tosylate (DRUG).
Who is sponsoring clinical trial NCT06243835?
This trial is sponsored by Lohocla Research Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.